Evidence map›Paper›PMID 40778059›Full record

ArticleFrontiers in urology2023

Intermittent catheterization: A patient-centric approach is key to optimal management of neurogenic lower urinary tract dysfunction.

Andrei Krassioukov, Blayne Welk, Desiree Vrijens, Sabrina Islamoska, Kim Bundvig Barken, Veronique Keppenne, Michel Wyndaele, Matthias Walter

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Frontiers in urology, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Andrei KrassioukovInternational Collaboration on Repair Discoveries (ICORD), Faculty of Medicine, The University of British Columbia (UBC), Vancouver, BC, Canada.
Blayne WelkDepartment of Surgery and Epidemiology & Biostatistics, Western University, London, ON, Canada.
Desiree VrijensDepartment of Urology, Maastricht University Medical Center, Maastricht, Netherlands.
Sabrina IslamoskaEvidence & Education Medical Affairs, Coloplast A/S, Humlebaek, Denmark.
Kim Bundvig BarkenEvidence and Adoption Medical Affairs, Coloplast A/S, Humlebaek, Denmark.
Veronique KeppenneDepartment of Urology, Centre Hospitalier Universitaire (CHU) de Liege, Liege, Belgium.
Michel WyndaeleDepartment of Urology, University Medical Center Utrecht, Utrecht, Netherlands.
Matthias WalterInternational Collaboration on Repair Discoveries (ICORD), Faculty of Medicine, The University of British Columbia (UBC), Vancouver, BC, Canada.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The value of disposable, single-use catheters has come under scrutiny in recent years with a growing attention on environmental sustainability. Intermittent catheterization (IC) is a widely available and minimally invasive technique for management of lower urinary tract dysfunction. Effective IC for individuals with neurogenic lower urinary tract dysfunction can promote their independence and improve quality of life. Are there alternative options within IC that could minimize environmental impact without compromising the safety and effectiveness of single-use catheters? How does the future of IC look - environmentally friendly, biodegradable, disposable catheters may be complementary to certified reusable catheters? In the midst of this debate, it is important to emphasize that individuals have the right to choose the best evidence-based treatment available. Here we consider the current landscape for IC with a focus on chronic use in individuals with neurogenic lower urinary tract dysfunction.

Indexed as

access to health careintermittent catheterizationneurogenic lower urinary tract dysfunctionneurourologypatient safety

Identifiers

PMID40778059
PMCPMC12327246

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.